News

Lilly’s Kisunla marketing for Alzheimer’s authorised in Australia
The decision to register the therapy was supported by data from the Phase III TRAILBLAZER-ALZ 2 and TRAILBLAZER-ALZ 6 trials.
FDA OKs first blood test that can help diagnose Alzheimer's disease
The test can aid doctors in determining whether a patient's memory problems are due to Alzheimer's or a number of other ...